Rwanda vs Sierra Leone: Reported cases of paralytic polio by world region
Rwanda
0 cases
in 2023
Sierra Leone
0 cases
in 2023
Rwanda rank
26th
Sierra Leone rank
26th
Reported cases of paralytic polio by world region over time
- Rwanda
- Sierra Leone
How they compare
Rwanda currently reports 0 cases against 0 cases in Sierra Leone, a difference of 0 cases.
The two have swapped places 7 times across 43 shared years of data; in 1980 it was Rwanda ahead.
Rwanda ranks 26th and Sierra Leone ranks 26th of 199 countries.
Sierra Leone has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Rwanda | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 18.7 cases | 39.3 cases | 20.6 cases | Sierra Leone |
| 1990s | 4.22 cases | 14.33 cases | 10.11 cases | Sierra Leone |
| 2000s | 0 cases | 4.5 cases | 4.5 cases | Sierra Leone |
| 2010s | 0 cases | 0.1 cases | 0.1 cases | Sierra Leone |
| 2020s | 0 cases | 3.75 cases | 3.75 cases | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported cases of paralytic polio by world region, Rwanda or Sierra Leone?
- Rwanda, at 0 cases against 0 cases in Sierra Leone as of 2023.
- What is the difference in reported cases of paralytic polio by world region between Rwanda and Sierra Leone?
- 0 cases, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Sierra Leone?
- 43 years are reported by both, from 1980 to 2023.
- How do Rwanda and Sierra Leone rank globally for reported cases of paralytic polio by world region?
- Rwanda ranks 26th and Sierra Leone ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported cases of paralytic polio by world region. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.